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ABSTRACT
Objective: This study aimed to determine the stability of anti-aging cream using the accelerated stability test and calculating the levels of myristic 
acid and stearic acid as degradation products.
Methods: Optimum conditions and validation methods for the mixture of myristic acid and stearic acid were determined to obtain a valid method for 
determining the levels of degradation products in anti-aging cream. Derivatization was performed with the Lepage esterification method, which uses 
methanol-toluene 4:1 (v/v) and acetyl chloride catalysts. The analysis was performed using gas chromatography (GC) Shimadzu GC-17A system with 
an HP-1 column and flame ionization detection.
Results: The column temperature was 120°C, with an increase of 10°C/min (up to 160°C) followed by an increase of 3°C/min (up to 220°C; 
maintained for 5 min) and an increase of 10°C/min (up to 260°C; maintained for 5 min). The injector and detector temperatures were 260°C and 
280°C, respectively, with a flow rate of 1 mL/min. The retention times of myristic acid and stearic acid were 16.655 min and 28.169 min, respectively, 
with tailing factor values of 0.734 and 0.943, respectively. Validation results fulfilled our acceptance criteria, which obtained linearity for myristic 
acid at y=9.6483+190.78x, with a correlation coefficient (r) value of 0.9997, limit of detection (LOD)=0.0013 parts per million (ppm), and limit 
of quantification (LOQ)=0.0042 ppm. The linearity for stearic acid was determined at y=17.163+106.22x, with a correlation coefficient (r) value 
of 0.9998, LOD=0.0016 ppm, and LOQ=0.0053 ppm. Results of the anti-aging cream stability test indicated that the average remaining levels of 
isopropyl myristate from 0 to 3 months were 99.6283%, 99.1995%, 98.2571%, and 97.1511%, respectively. The average remaining levels of glyceryl 
monostearate were 99.6791%, 98.2881%, 96.2247%, and 93.7195% from 0 to 3 months, respectively.
Conclusion: The expiration date of the anti-aging cream product was then calculated using zero-order kinetics and determined to be 10 months and 
9 days.
Keywords: Myristic acid, Stearic acid, Isopropyl myristate, Glyceryl monostearate, Gas chromatography, Accelerated stability test, Validation, 
Optimization.
INTRODUCTION
Since ancient times, beauty has been a highly desirable trait, with skin 
being an outward reflection. Indeed, the skin is one part of the body where 
beauty can be more precisely defined. However, with age, the properties of 
skin can change. Indeed, extreme climate changes, high levels of pollution, 
smoking, hormonal changes, lifestyle, and ultraviolet (UV) exposure can 
all aggravate skin aging [1,2]. Characteristic signs of aging skin include 
reduced skin elasticity, wrinkles, and skin that appears to be thin [1].
At present, various techniques have been developed to prevent and 
treat skin aging, with one being the use of cosmetics [3]. Accordingly, 
cosmetics are widely used to overcome the problem of skin aging. Anti-
aging cosmetics function to rejuvenate the skin, help remove wrinkles, 
and protect the skin from oxidative damage caused by UV rays [4,5]. 
The anti-aging products currently available on the market are generally 
formulated as transparent creams and gels [6]. However, cream 
preparations are more popular, likely because they are easy to apply 
and easily removed from the skin [7].
Anti-aging cream products, as well as cosmetic creams in general, are 
composed of two main components, namely, the oil phase and the water 
phase. Cream preparations generally contain >20% water content and 
<50% of the oil phase [8]. Some ingredients often used as oils or as 
the lipophilic phase in creams include ester compounds of fatty acids, 
including sorbitan monooleate, polyoxyl 40 stearate, glyceryl dilaurate, 
glyceryl oleate, glyceryl monostearate (GMS), and isopropyl myristate [9].
GMS is one of the ester fatty acid compounds used in lotions and 
creams as an emulsifier, stabilizer, thickener, and emollient and is the 
most widely sold emulsifier commercially. In addition to GMS, isopropyl 
myristate is an important ingredient used in cosmetics, functioning as 
an emollient that can restore and retain the natural softness of the 
skin [10]. However, when the water content is high, as in the preparation 
of creams under acidic conditions, the ester bonds in both GMS and 
isopropyl myristate become broken, which leads to their break down 
into various degradation products. Accordingly, isopropyl myristate 
breaks down into isopropanol isopropyl myristate and myristic acid, 
while GMS decomposes into stearic acid and glycerol [11,12]. Based on 
this decomposition, the stability of anti-aging cream preparations can 
be evaluated.
The stability test is composed of a series of tests aimed at obtaining 
information on the stability of pharmaceutical products, to determine 
their shelf life and expiration date under certain packaging and storage 
conditions [13]. The long-term stability test is often performed to 
produce more significant degradation data for preparation [14]. 
However, this stability test takes a long time to determine the expiration 
date, which precludes timely cosmetic notification processes for 
production. Therefore, the preferred stability test is the accelerated 
method, which requires shorter test times, where the decomposition 
may cause the consistency of the cream to change [13,14]. Therefore, 
in this study, we performed the accelerated stability test at 40°C±2°C 
and a relative humidity of 70±5% to accelerate the expiration date of 
Research Article
© 2018 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
org/licenses/by/4. 0/) DOI: http://dx.doi.org/10.22159/ijap.2018.v10s1.01
The 2nd Physics and Technologies in Medicine and Dentistry Symposium (PTMDS), Universitas Indonesia. Depok, Indonesia
 The 2nd Physics and Technologies in Medicine and Dentistry Symposium (PTMDS), Universitas Indonesia. Depok, Indonesia 2
Int J App Pharm, Vol 10, Special Issue 1, 2018
 Iskandarsyah et al. 
the product. Data acquisition was based on the remaining isopropyl 
myristate and GMS in the product at 0, 1, 2, and 3 months.
In previous studies, stability tests were conducted on cosmetic 
preparations using the accelerated method for 90 days, a temperature of 
40°C, and a relative humidity of 75%. In addition, tests were performed 
at room temperature. After the test, the physical properties of the 
preparation, such as organoleptic, pH, viscosity, and the levels of active 
substances were observed [2]. While there has been an increasing use 
of anti-aging creams, little data exist on the stability of the chemicals in 
these creams; thus, it is necessary to study the components of cream 
preparations.
In this study, accelerated stability testing was conducted on the 
preparation of anti-aging creams containing isopropyl myristate and 
GMS as their base components. The stability of the anti-aging cream was 
judged by determining the residual isopropyl myristate levels, based 
on the formation of myristic acid, and the residual GMS levels, based 
on the formation of stearic acid. Considering the fatty components 
of the cream, gas chromatography (GC) methods were chosen as the 
best technique. Indeed, GC is the method most often used for the 
analysis of fatty acids and is very sensitive for their identification and 
quantification [15]. However, fatty acids detected using GC processes 
first require derivatization to lower their boiling point, and the response 
to the detector used [16]. In this study, derivatization was performed 
using the Lepage esterification method, followed by analysis using GC.
METHODS
Samples
The anti-aging cream used for accelerated stability testing at 0, 1, 2, 
and 3 months was composed of a formulation of glycolic acid (10%), 
Lanette O (5%), isopropyl myristate (5.5%), GMS (4.5%), emulgade 
SE-PF (3.5%), propylene glycol (5%), glycerin (5%), methylparaben 
(0.01%), propylparaben (0.002%), and water (ad 100%).
Chemical material
A myristic acid standard (Natural Oleochemicals Sdn Bhd), stearic 
acid standard (Edenor), isopropyl myristate standard (Oleon), GMS 
standard (Evonik), acetyl chloride (Merck), methanol p.a (Merck), 
toluene p.a (Merck), potassium carbonate (Merck), nitrogen (UHP dan 
HP), and hydrogen (UHP) were all of reagent grade or higher.
Chromatographic condition
Shimadzu GC-17A systems are equipped with a flame ionization 
detector, a capillary column with a length of 30 m and an inside 
diameter of 0.25 mm, film thickness of 0.25 μm with a stationary phase 
HP-1, and carrier gases of nitrogen and hydrogen. The solution class GC 
data processor had an initial column temperature of 1200°C, which was 
increased 10°C/min (up to 160°C), then raised 3°C/min (up to 220°C; 
maintained for 5 min). Then, the temperature was raised 10°C/min (up 
to 260°C; maintained for 5 min). The injector and detector temperatures 
were set at 260°C and 280°C, respectively. The carrier gas flow rate was 
1.0 mL/min.
Preparation of potassium carbonate solution (6%)
Approximately 6 g of K2CO3 was carefully weighed and placed into a 
100 mL volumetric flask, followed by dilution with distilled water to 
mark the boundaries of the flask.
Preparation of the myristic acid stock solution
Approximately 25 g of myristic acid standard was carefully weighed 
and placed into a 25 mL volumetric flask followed by dilution with 
methanol-toluene 4:1 (v/v) to mark the boundaries of the flask.
Preparation of the stearic acid stock solution
Approximately 25 g of the stearic acid standard was carefully weighed 
and placed into a 25 mL volumetric flask followed by dilution with 
methanol:toluene 4:1 (v/v) to mark the boundaries of the flask.
Determination of optimum conditions
To determine the optimum conditions for testing, as much as 1.0 mL of 
each test solution of 4 parts per million (ppm) was pipetted and mixed. 
The solution was then placed in a test tube stoppered and shaken with 
a vortex. Acetyl chloride (1 μL) was then added slowly while stirring. 
The tube was sealed while shaking occasionally. Furthermore, 5.0 mL 
of 6% potassium carbonate solution was slowly added. The tube was 
then tightly closed and centrifuged at 3000 rpm for 5 min. The top 
layer (toluene phase), containing the methyl ester mixture of myristic 
acid and stearic acid, was injected (1 μL) into the GC system. Optimum 
conditions for analysis were assessed by retention time, the number 
of theoretical plates (N), height equivalent to a theoretical plate, 
tailing factor, and the best separation resolution in Table 1.
Analysis of the effect of heating time on placebo
The placebo, weighing as much as 200 mg, was then fed into a 100 mL 
measuring flask and dissolved in 4:1 (v/v) methanol: toluene, up to the 
boundary marker. Then, 200 μL of acetyl chloride was added slowly 
while stirring. The tube was then placed into a water bath at 100°C for 
10 min, 5 min, and without heating. The tube was then sealed while 
shaking occasionally. 5 mL of 6% potassium carbonate solution was 
then slowly added. The tube was then tightly closed and centrifuged at 
3000 rpm for 5 min. The top layer (toluene phase), containing the methyl 
ester mixture of myristic acid and stearic acid, was injected (1 μL) into 
the GC system. Based on the results of our analysis, the peak area and 
comparative peak areas of myristic acid and stearic acid were recorded 
with each variation in conditions.
Analysis of the addition of acetyl chloride to placebo
The placebo, weighing as much as 200 mg, was then fed into a 100 mL 
measuring flask and dissolved in 4:1 (v/v) methanol: toluene, up to the 
boundary marker. Acetyl chloride was then added slowly while stirring, 
with the variation of addition volume being 10 μL, 5 μL, and 1 μL. The 
tube was sealed while shaking occasionally. Furthermore, 5.0 mL of 6% 
potassium carbonate solution was slowly added. The tube was then tightly 
closed and centrifuged at 3000 rpm for 5 min. The top layer (toluene phase), 
containing the methyl ester mixture of myristic acid and stearic acid, was 
injected (1 μL) into the GC system. Based on our results of the analysis, the 
peak areas of myristic acid and stearic acid were observed for each variation.
System conformity test
Sample preparation was performed in accordance with procedures 
for determining the optimum conditions for analysis. The injection of 
each solution was performed up to 6 times. The results of the analysis 
were recorded and the coefficient of variation was counted (% KV). The 
acceptance criteria of %KV were 2% or less.
Validation of the GC analytical method
Linearity test of myristic acid and stearic acid
Test solutions of myristic acid and stearic acid (10 ppm) were 
prepared at 100 μL and 500 μL. Aliquots (1.0, 2.0, 4.0, and 8.0 mL) 
were then inserted into a 10 mL measuring flask. A sufficient volume 
of methanol:toluene solution 4:1 (v/v) was used to obtain standard 
solutions of concentration: 0.1; 0.5; 1; 2; 4; and 8 ppm.
Detection limit test (LOD) and quantitation limit (LOQ)
The LOD and LOQ were calculated statistically by linear regression 
calibration curves. The calculation results were equal to the value of 
Table 1: Variation of initial column temperature and flow rate 
for determining the optimum conditions for analyzing myristic 
acid and stearic acid content
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b in the straight-line equation y=a+bx, whereas the standard deviation 
of the blank was equal to the residual standard deviation (Sy/x) [17].
Selectivity test
The selectivity test was carried out by preparing a standard solution 
of myristic acid and stearic acid, and a derivatization solution with no 
standard added. Each solution was injected into the GC at 1 μL under 
the selected analysis conditions. It was then observed whether or not 
other peaks appeared at the time of the retention of the methyl esters 
of myristic acid and stearic acid in the sample solution.
Precision accuracy test
The placebo cream, weighing as much as 200 mg, was added to each 
standard solution, then dissolved in a 100 mL volumetric flask using 
methanol:toluene 4:1 (v/v). The volume of standard solution added 
was calculated to obtained concentrations of 80% (3.2 μg/mL), 100% 
(4 μg/mL), and 120% (4.8 μg/mL).
RESULTS AND DISCUSSION
Analysis conditions optimization
Based on our experiments, the resulting optimum analysis conditions 
for analyzing the mixture of myristic acid and stearic acid were: An 
initial temperature of 120°C for the column and a mobile phase flow 
rate of 1.0 mL/min (Table 2). The resulting chromatogram had a fairly 
large peak area and relatively shorter retention time but displayed the 
best resolution when compared with other variations. The peak area 
obtained under these conditions was 749 μV/s. The retention time 
obtained from the chromatogram of myristic acid was approximately 
16.655 min.
For stearic acid, the peak area obtained under these conditions was 
451 µV/s. The retention time obtained from the chromatogram for myristic 
acid was 28.169 min. The retention times for myristic acid and stearic acid 
are known and confirmed by the analysis of each substance under the 
selected analysis conditions, that is, the initial temperature of the column 
was 1200°C and the carrier gas flow rate was 1.0 mL/min. The resultant 
chromatogram was obtained and myristic acid appeared at a retention time 
of 16.251 min, while stearic acid appeared at a retention time of 28.986 min.
System conformity test
The system suitability test should be performed first before analyzing 
the optimum conditions selected. A number of variations made to the 
equipment, as well as the analytical techniques used, were evaluated. 
Thus, it is necessary to test the suitability of the system to ensure 
the effectiveness of the operational systems and to deliver results in 
accordance with the purpose of the analysis. The system suitability 
test was performed 6 times in a row and yielded coefficients of 
variation for the mixture of myristic acid and stearic acid of 0.9999% 
and 1.0433%, respectively. Based on these experiments, our results 
matched the requirement that the coefficient of variation (KV) does 
not exceed 2%.
Analysis of the effect of heating on placebo
In this experiment, we analyzed the effect of heating on the placebo-
based cream containing isopropyl myristate and GMS. This analysis 
was performed by varying the Lepage esterification procedure used, 
that is, by heating at 1000°C for 10 min, 5 min, and without heating. 
In this experiment, acetyl chloride as a catalyst was still used with an 
additional volume of 200 μL. The test results showed that the peak 
area of analysis using the same warming was slightly larger than those 
without the use of heating (Figs. 1 and 2). This likely occurred because 
in the presence of heating the reaction is catalyzed and may decompose 
into isopropyl myristate and GMS [18,19]. Thus, the chosen method 
of esterification without heating to reduce the effect of the reaction of 
isopropyl myristate and GMS was considered optimal.
Analysis of the addition of acetyl chloride to the placebo in 
conditions without heating
After analyzing the effect of heating on the placebo, we analyzed the 
effect of the amount of acetyl chloride added to the placebo. This 
analysis was conducted to determine whether the addition of acetyl 
chloride can cause isopropyl myristic and GMS to break down, which 
should not decompose during the preparation process. Variations 
in the volume used included 10 µL, 5 µL, and 1 µl. Our test results 
showed that the peak area decreases with the increase in volume 
added (Figs. 3 and 4). Thus, the optional addition volume of 1 μL, due 
to the smaller amount of acetyl chloride added, may minimize the 
possibility of reacting with the remaining isopropyl myristate and 
GMS. In this case, the acid reacted only with myristic acid and stearic 
acid as a result of the decomposition. This may occur because acetyl 
Fig. 1: Comparison of the peak area of myristic acid in the analysis 
of the effect  of heating on the placebo
Fig. 2: Comparison of the peak area of stearic acid in the analysis 
of the effect of heating on the placebo
Table 2: Optimization of analysis condition for mixture of myristic and stearic acid
Initial column temperature (°C)
100 120 140
Flow rate (mL/min)
1.0 1.2 1.5 1.0 1.2 1.5 1.0 1.2 1.5
Retention time (min) 19.057 18.001 16.842 16.655 15.438 14.218 13.629 12.477 11.166
Peak area (µV/s) 689 557 804 749 658 1001 1302 1237 1587
Theoretical plate (N) (plates) 480866 424006 391146 391327 332864 232531 202990 185770 115155
HETP (cm) 0.0062 0.0071 0.0077 0.0077 0.0090 0.0129 0.0147 0.0161 0.0260
Resolution 163.61 163.36 159,61 145.00 145.17 115.35 55.51 51.082 44.616
(Tf) 0.73 0.76 0.94 0.81 0.84 0.81 0.80 0.71 0.77
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chloride is a strong acid that can catalyze the reaction, including both 
hydrolysis and esterification reactions [20].
Validation of analysis methods
Selectivity test
The selectivity test was performed by injecting the esterified product 
from the blank solution containing no fatty acids. The purpose of this 
test was to look at the possibility of a disturbance around the retention 
time of the fatty acid methyl esters. The results of these tests showed 
that the method was selective because there was no interference in the 
retention times of myristic acid and stearic acid.
Linearity test
The linearity test was performed by making a calibration curve by using 
six concentrations of the mixture of myristic acid and stearic acid, which 
were: 0.1, 0.5, 1.0, 2.0, 4.0, and 8.0 ppm. The regression equations for 
myristic acid and stearic acid were y=191.17x+7.4638 ([r]=0.9997) and 
y=107.06x+12.482 ([r]=0.9996), respectively. Based on these results, 
the linearity test was declared valid because it met the linearity criteria 
of having a correlation coefficient of close to 1 or >0.9990.
Accuracy and precision test
Based on the results of our analysis, we calculated the percentage of 
recovery (UPK) by comparing the results of the analysis with the actual 
results. The criteria of accuracy were expressed as met if the percentage 
recovery (% UPK) obtained was 98–102%. The precision was 
determined as a relative standard deviation or coefficient of variation 
(KV). The criteria of the precision were considered met if the method 
used produced a coefficient of variation (KV) of 2% or less.
Based on the results of our analysis, we obtained a value of recovery 
(UPK) for myristic acid and stearic acid of approximately 99.74–
101.98% and 98.19– 101.51%, respectively. The value of the coefficient 
of variation (KV) produced for myristic acid and stearic acid was 0.49–
0.89% and 1.14–1.79%, respectively. Based on these results, it can be 
stated that the method used to analyze the mixture of myristic acid and 
stearic acid met the criteria of precision (accuracy) and precision.
Existence test of free myristic acid and stearic acid on isopropyl 
myristic and GMS
In this study, we tested the existence of free myristic acid and stearic 
acid in isopropyl myristate and GMS. Based on the chromatogram of 
the analytical results obtained, we did not observe any free myristic 
acid or stearic acid in the standard isopropyl myristate and GMS. This 
is consistent with the information contained in the data sheet for each 
substance, which does not indicate the presence of free myristic acid or 
stearic acid in isopropyl myristic and GMS.
Data stability analysis of anti-aging cream samples
In this study, we analyzed the stability of samples of anti-aging 
creams after 0, 1, 2, and 3 months. Before the analysis, each sample 
was dissolved first using a 4:1 (v/v) methanol:toluene solution, then 
reacted with acetyl chloride (1 μL) and no heating. After that, 5.0 mL 
Fig. 3: Comparison of the peak area of myristic acid with 
additional volumes of acetyl chloride in the placebo
Fig. 4: Comparison of the peak area of stearic acid with additional 
volumes of acetyl chloride in the placebo
Table 3: Chemical stability data of isopropyl myristate
Sample  
(months)
Peak area of 
sample (µV/s)
Peak area of 
placebo (µV/s)
Peak area of myristic 
acid as decompose 
product (µV/s)




Average level of 
remaining IPM (%)
0 1989 1930 59 0.3063 99.7215 99.6284
2022 92 0.5111 99.5353
1 2076 1930 146 0.8464 99.2305 99.1995
2087 157 0.9147 99.1684
2 2243 1930 313 1.8830 98.2881 98.2571
2254 324 1.9513 98.2261
3 2439 1930 509 3.0997 97.1821 97.15105
2450 520 3.1680 97.1200
IPM: Integrated pest management
Table 4: Chemical stability data of GMS
Sample  
(months)
Peak area of 
sample (µV/s)
Peak area of 
placebo (µV/s)
Peak area of myristic acid as 
decompose product (µV/s)




Average level of 
remaining GMS (%)
0 699 1930 38 0.2472 99.7253 99.6791
706 45 0.3303 99.6329
1 802 1930 141 1.4694 98.3672 98.2881
814 153 1.6118 98.2090
2 959 1930 298 3.3325 96.2972 96.22471
970 309 3.4630 96.1522
3 1151 1930 490 5.6108 93.7657 93.7196
1158 497 5.6938 93.6734
GMS: Glyceryl monostearate
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of 6% solution of potassium carbonate was added and the solution was 
centrifuged at 3000 rpm for 5 min. The toluene layer formed was then 
injected into the GC system at 1 μL.
In this study, the Lepage esterification procedure used was modified for the 
amount of added acetyl chloride reagent, that is, from 200 μL to 1 μL and 
without the use of heating. This was due to the excessive use of acetyl 
chloride and heating time for 60 min, which can cause GMS to decompose 
entirely into stearic acid, as well as isopropyl myristate to decompose 
entirely into myristic acid. Reactions that occur as a result of the hydrolysis 
of the ester compound can lead to the ester compound decomposing into 
a carboxylic acid in the presence of a catalyst, in the form of heat or acid. 
If such reactions occur in a cream base that does not decompose, it can 
hinder the process of decomposition analysis and the stability preparation 
test. In samples from the monthly stability tests, there were fatty acids, 
namely myristic acid and stearic acid, present into the 3rd month. The 
levels of myristic acid and stearic acid contained in each sample as a result 
of decomposition were calculated using a linear regression equation with 
concentrations corresponding to the range of the obtained content.
Based on our analysis results the levels of isopropyl myristate and GMS 
decreased from 0 to 3 months. Thus, the average level of isopropyl 
myristate remaining in the sample was equal to 99.6283%, 99.1995%, 
98.2571%, and 97.1511% from months 0 to 3, respectively (Table 3). 
The average GMS content remaining was 99.6791%, 98.2881%, 
96,2247%, and 93.7195% from months 0 to 3, respectively (Table 4). 
Increased levels of isopropyl myristate and GMS were found to degrade 
into myristic acid and stearic acid, which can occur due to the hydrolysis 
reaction of the ester compound. This reaction occurs due to the water 
content contained in the cream, and the glycolic acid aids as a catalyst 
to accelerate the reaction. Thus, the longer the carboxylic acid ester 
compound is exposed to the water content and the acid catalyst, the 
more the ester compound decomposes and forms the carboxylic acid, 
that is, free fatty acids.
CONCLUSION
The results of the anti-aging cream stability test indicated that the 
average remaining levels of isopropyl myristate from 0 to 3 months 
were 99.6283%, 99.1995%, 98.2571%, and 97.1511%, respectively. 
The remaining levels of GMS were 99.6791%, 98.2881%, 96.2247%, 
and 93.7195 from 0 to 3 months, respectively. The expiration date of the 
anti-aging cream product was calculated using zero-order kinetics and 
determined to be 10 months and 9 days. Increased levels of isopropyl 
myristate and GMS degraded into myristic acid and stearic acid occur 
due to the hydrolysis reaction of the ester compound.
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